Segantii Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Segantii Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,261	Closed	-$555K	–	593
2022 Q1	$555K	Sell	4,261 -8,400	-66%	-$1.09M	0.02%	327
2021 Q4	$1.93M	Buy	+12,661	New	+$1.96M	0.06%	149
2021 Q1	–	Sell	-26,300	Closed	-$3.98M	–	352
2020 Q4	$3.98M	Buy	+26,300	New	+$3.76M	0.18%	65
2019 Q3	–	Sell	-12,900	Closed	-$1.41M	–	92
2019 Q2	$1.41M	Buy	+12,900	New	+$1.37M	0.12%	51

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Segantii Capital Management's IBB Position: Q2 2022 in Review

Segantii Capital Management sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 4,261 shares — an estimated $555K sold.

Segantii Capital Management first reported a position in IBB in Q2 2019 and held it in 4 quarters. The position peaked at $3.98M in Q4 2020. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

Segantii Capital Management reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
Segantii Capital Management sold 4,261 iShares Biotechnology ETF shares in Q2 2022, an estimated $555K.
Segantii Capital Management first reported a position in iShares Biotechnology ETF in Q2 2019 and held it in 4 quarters.
Segantii Capital Management's iShares Biotechnology ETF position peaked at $3.98M in Q4 2020.
858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on Segantii Capital Management's 13F filing for Q2 2022, filed 3 Aug 2022.